Welcome to our dedicated page for Metropolitan Bank Holding SEC filings (Ticker: MCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Metropolitan Bank Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Metropolitan Bank Holding's regulatory disclosures and financial reporting.
Form 144 notice for Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 5,000 shares of common stock through J.P. Morgan Securities with an approximate sale date of 08/27/2025 and an aggregate market value of $395,550. The filing shows total shares outstanding of 10,421,384, and states the 5,000 shares were originally received as board compensation (4,100 shares on 12/08/2016 and 900 shares on 08/11/2018). The notice also lists recent sales by the same holder in the past three months: 5,000 shares on 07/11/2025 (gross proceeds $391,845) and two sales on 08/20/2025 totaling 5,000 shares (gross proceeds $152,891 and $210,840).
Terence J. Mitchell, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of common stock on 08/19/2025. The Form 4 shows 4,796 shares sold at a weighted average price of $72.4401, with prices in the transactions ranging from $72.1801 to $72.5800. After the sale, the reporting person beneficially owns 13,230 shares, which includes restricted stock units that vest 100% on January 27, 2026. The filing indicates the report was signed by an attorney-in-fact on 08/21/2025. All information is limited to the transactions and holdings disclosed on the Form 4.
Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of 5,000 shares of the issuer's common stock on 08/19/2025 at a weighted-average price of $72.7460 per share. After the reported transaction, the reporting person directly beneficially owns 103,685 shares.
The filing also shows indirect holdings of 32,882 shares via a sibling (over which the reporting person holds a power of attorney but disclaims beneficial ownership) and 14,445 shares held indirectly through a profit sharing plan. The report notes restricted stock units that vest 100% on January 27, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/21/2025.
The filing is a Form 144 notification for the proposed sale of 4,796 shares of common stock to be executed on or about 08/19/2025 on the NYSE. The filing lists an aggregate market value of $347,228.36 and reports 10,421,384 shares outstanding. The 4,796 shares were acquired through restricted stock vesting on three dates—12/31/2021 (1,296 shares), 02/01/2023 (1,000 shares) and 01/24/2025 (2,500 shares)—and were issued as fees for service as director. The broker listed for the sale is Osaic Wealth, Inc., with an address in Red Bank, NJ. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Form 144 notice from Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 5,000 common shares through J.P. Morgan Securities LLC with an aggregate market value of $363,700, scheduled approximately for 08/19/2025 on the NYSE. The filing shows those 5,000 shares equal the cumulative shares received as board compensation across multiple grant dates between 2017 and 2023. The issuer has 10,421,384 shares outstanding, and the filer reports no securities sold in the past three months. The signer also certifies they are not aware of any undisclosed material adverse information about the issuer.
Metropolitan Bank Holding Corp. (MCB) filed a Form 144 indicating an insider’s intention to sell up to 1,400 common shares through Fidelity Brokerage on the NYSE. Based on the filing’s stated market value of $111,020, the proposed transaction equals roughly 0.013 % of the company’s 10,660,109 shares outstanding, suggesting minimal market impact. The shares were originally acquired via open-market purchases—1,000 shares on 05/13/2022 and 400 shares on 03/13/2023—and are slated for sale on or after 07/22/2025. The filer reports no sales in the past three months and certifies awareness of no undisclosed adverse information. While quantitatively small, the notice provides transparency into insider activity and may be monitored by investors tracking sentiment.